These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2226234)

  • 1. The history of interferon and its use in animal therapy.
    Young AS; Cummins JM
    East Afr Med J; 1990 Jul; 67(7 Suppl 2):SS31-63. PubMed ID: 2226234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects.
    Billiau A
    J Clin Virol; 2007 Aug; 39(4):241-65. PubMed ID: 17580123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of interferon therapy].
    Dittrich C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha interferons: clinical overview.
    Spiegel RJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):1-12. PubMed ID: 3296210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The interferon system. A review of biological principles and clinical uses].
    Schneider FJ
    Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental research to clinical application of interferons].
    Imamishi J; Tanaka A
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-induced alterations in cells: relevance to viral and nonviral diseases.
    Preble OT; Friedman RM
    Lab Invest; 1983 Jul; 49(1):4-18. PubMed ID: 6191121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
    Furue H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and pharmacological aspects of interferons].
    Kiuch Y
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):36-43. PubMed ID: 6421242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.
    Naldini A; Fleischmann WR
    J Biol Response Mod; 1987 Oct; 6(5):546-55. PubMed ID: 3119781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases.
    Dec M; Puchalski A
    Pol J Vet Sci; 2008; 11(2):175-86. PubMed ID: 18683548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.